Bulletin
Investor Alert

Kintara Therapeutics Inc.

NAS: KTRA

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jun 27, 2022, 7:55 p.m.

/zigman2/quotes/209332458/composite

$

0.31

Change

+0.0001 +0.03%

Volume

Volume 12,491

Quotes are delayed by 20 min

/zigman2/quotes/209332458/composite

Today's close

$ 0.29

$ 0.31

Change

+0.02 +8.74%

Day low

Day high

$0.29

$0.32

Open

52 week low

52 week high

$0.14

$2.85

Open

John K. Bell

Transactions

Date Shares Transaction Value
06/30/2020 29   0
03/31/2020 29   0
12/31/2019 29   0
09/30/2019 29   0
09/13/2019 35,000   Acquisition at $0.68 per share. 23,800
06/28/2019 29   0
03/29/2019 282   138
12/31/2018 282   95
09/28/2018 282   902
06/29/2018 282   902
03/30/2018 282   902
12/31/2017 282   902
11/16/2017 18,129   Acquisition at $0.81 per share. 14,684
11/15/2017 1,871   Acquisition at $0.81 per share. 1,515
09/29/2017 282   902
08/01/2017 25,000   Derivative/Non-derivative trans. at $0 per share. 0
06/30/2017 282   902

Officers and Executives

Mr. Robert E. Hoffman
Chairman, President & Chief Executive Officer
Mr. Greg A. Johnson
Operations Head
Mr. Scott Praill
Chief Financial Officer & Secretary
Dr. Dennis M. Brown
Chief Scientific Officer
Ms. Laura Johnson Douglass
Independent Director
Ms. Tamara A. Seymour
Independent Director
Mr. Robert Joseph Toth
Independent Director
Link to MarketWatch's Slice.